• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

氢可酮:它在姑息治疗中有作用吗?

Hydrocodone: does it have a role in palliative care?

作者信息

Prommer Eric

机构信息

Department of Hematology/Oncology/Palliative Care, Mayo Clinic, Phoenix, Arizona, USA.

出版信息

J Opioid Manag. 2010 Jul-Aug;6(4):295-9. doi: 10.5055/jom.2010.0027.

DOI:10.5055/jom.2010.0027
PMID:20862909
Abstract

Hydrocodone is an epoxy-methoxy-methylmorphinan semisynthetic opioid (6-deoxy-3-O-methyl-6-oxomorphine hydrogen tartrate hemipentahydrate), which is structurally related to codeine, and is classified as a step 2 opioid on the World Health Organization's stepladder for pain. Hydrocodone is typically found in fixed dose combination with acetaminophen and is often used for pain management. Hydrocodone is a heavily prescribed drug and it is important to understand the evidence base that is guiding this use. This article reviews the pharmacodynamics, pharmacology, and evidence base for the use of hydrocodone in palliative care.

摘要

氢可酮是一种环氧甲氧基甲基吗啡喃半合成阿片类药物(6-脱氧-3-O-甲基-6-氧代吗啡氢酒石酸半五水合物),其在结构上与可待因相关,在世界卫生组织疼痛阶梯分类中属于第2级阿片类药物。氢可酮通常以与对乙酰氨基酚的固定剂量组合形式存在,常用于疼痛管理。氢可酮是一种大量开具处方的药物,了解指导其使用的证据基础很重要。本文综述了氢可酮在姑息治疗中使用的药效学、药理学及证据基础。

相似文献

1
Hydrocodone: does it have a role in palliative care?氢可酮:它在姑息治疗中有作用吗?
J Opioid Manag. 2010 Jul-Aug;6(4):295-9. doi: 10.5055/jom.2010.0027.
2
Codeine/acetaminophen and hydrocodone/acetaminophen combination tablets for the management of chronic cancer pain in adults: a 23-day, prospective, double-blind, randomized, parallel-group study.可待因/对乙酰氨基酚和氢可酮/对乙酰氨基酚复方片剂用于成人慢性癌痛的管理:一项为期23天的前瞻性、双盲、随机、平行组研究。
Clin Ther. 2007 Apr;29(4):581-7. doi: 10.1016/j.clinthera.2007.04.004.
3
Pharmacokinetic evaluation of hydrocodone/acetaminophen for pain management.氢可酮/对乙酰氨基酚用于疼痛管理的药代动力学评估。
J Opioid Manag. 2013 Jan-Feb;9(1):71-80. doi: 10.5055/jom.2013.0149.
4
Hydrocodone bitartrate for chronic pain.用于慢性疼痛的酒石酸氢可酮。
Drugs Today (Barc). 2015 Jul;51(7):415-27. doi: 10.1358/dot.2015.51.7.2361328.
5
Incidence of weak opioids adverse events in the management of cancer pain: a double-blind comparative trial.弱阿片类药物在癌症疼痛管理中不良事件的发生率:一项双盲对照试验。
J Palliat Med. 2007 Feb;10(1):56-60. doi: 10.1089/jpm.2006.0117.
6
Combination hydrocodone and ibuprofen versus combination codeine and acetaminophen for the treatment of chronic pain.氢可酮与布洛芬联合用药对比可待因与对乙酰氨基酚联合用药治疗慢性疼痛
Clin Ther. 2000 Jul;22(7):879-92. doi: 10.1016/S0149-2918(00)80060-0.
7
Pain & opioid addiction: hydrocodone update & zohydro. The paradigm for the epidemic..... continues.疼痛与阿片类药物成瘾:氢可酮最新情况及佐氢可酮。这一流行模式……仍在持续。
W V Med J. 2014 Nov-Dec;110(6):6-10.
8
Efficacy and tolerability of celecoxib versus hydrocodone/acetaminophen in the treatment of pain after ambulatory orthopedic surgery in adults.塞来昔布与氢可酮/对乙酰氨基酚治疗成人门诊骨科手术后疼痛的疗效和耐受性比较
Clin Ther. 2001 Feb;23(2):228-41. doi: 10.1016/s0149-2918(01)80005-9.
9
Randomized clinical trial of hydrocodone/acetaminophen versus codeine/acetaminophen in the treatment of acute extremity pain after emergency department discharge.氢可酮/对乙酰氨基酚与可待因/对乙酰氨基酚治疗急诊科出院后急性四肢疼痛的随机临床试验。
Acad Emerg Med. 2014 Mar;21(3):227-35. doi: 10.1111/acem.12331.
10
Analgesic efficacy and tolerability of oxycodone 5 mg/ibuprofen 400 mg compared with those of oxycodone 5 mg/acetaminophen 325 mg and hydrocodone 7.5 mg/acetaminophen 500 mg in patients with moderate to severe postoperative pain: a randomized, double-blind, placebo-controlled, single-dose, parallel-group study in a dental pain model.在中度至重度术后疼痛患者中,比较5毫克羟考酮/400毫克布洛芬与5毫克羟考酮/325毫克对乙酰氨基酚以及7.5毫克氢可酮/500毫克对乙酰氨基酚的镇痛效果及耐受性:一项在牙科疼痛模型中的随机、双盲、安慰剂对照、单剂量、平行组研究。
Clin Ther. 2005 Apr;27(4):418-29. doi: 10.1016/j.clinthera.2005.04.010.

引用本文的文献

1
Management of pain in the elderly at the end of life.终末期老年患者的疼痛管理。
Drugs Aging. 2012 Apr 1;29(4):285-305. doi: 10.2165/11599210-000000000-00000.